{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:55:21Z","timestamp":1781711721237,"version":"3.54.5"},"reference-count":9,"publisher":"Norwegian Medical Association","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.25.0247","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T13:45:12Z","timestamp":1763387112000},"source":"Crossref","is-referenced-by-count":0,"title":["Cystoscopic injection of botulinum toxin for urgency incontinence"],"prefix":"10.4045","volume":"145","author":[{"given":"Siv Svennevik","family":"Myhr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hjalmar A.","family":"Schi\u00f8tz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"ref=1","unstructured":"Andersson K-E, Rodrigues CM, Cardozo L et al. Pharmacological treatment of urinary incontinence. Committee 9. 8.1 Botulinum Toxin. I: Cardozo L, Rovner E, Wagg A, red. Incontinence. 7. utg. Bristol: International Continence Society, 2023: 1102\u201317."},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Chancellor\u00a0MB. OnabotulinumtoxinA for overactive bladder and urinary incontinence. J Urol 2017; 197 (2S): S224\u20135. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28010976&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.juro.2016.11.077","DOI":"10.1016\/j.juro.2016.11.077"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Nitti\u00a0VW, Kohan\u00a0A, McCammon\u00a0K et al. Efficacy and safety of onabotulinumtoxinA for the treatment of overactive bladder in men and women: A pooled analysis. Neurourol Urodyn 2024; 43: 1765\u201375. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=38973548&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fnau.25538","DOI":"10.1002\/nau.25538"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Duthie\u00a0JB, Vincent\u00a0M, Herbison\u00a0GP et al. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev 2011; 12: CD005493. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22161392&dopt=Abstract","DOI":"10.1002\/14651858.CD005493.pub3"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Getaneh\u00a0FW, Simhal\u00a0R, Sholklapper\u00a0T et al. Antibiotic prophylaxis for onabotulinum toxin A injections: systematic review and meta-analysis. Int Urogynecol J 2024; 35: 19\u201329. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37938397&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs00192-023-05665-4","DOI":"10.1007\/s00192-023-05665-4"},{"key":"ref=6","unstructured":"Harding CK, Lapitan MC, Arlandis S et al. EAU Guidelines on non-neurogenic female Lower Urinary Tract Symptoms. 2024. https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Non-neurogenic-Female-LUTS-2025.pdf Lest 8.9.2025."},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Robinson\u00a0D, O'Kane\u00a0M, Cardozo\u00a0L. Adherence to overactive bladder syndrome treatments. Recent developments and future perspectives. Int J Womens Health 2023; 15: 799\u2013811. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37251090&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2147%2FIJWH.S369588","DOI":"10.2147\/IJWH.S369588"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Eckhardt\u00a0SE, Takashima\u00a0Y, Handler\u00a0SJ et al. Antibiotic regimen and route of administration do not alter rates of urinary tract infection after intravesical botulinum toxin injection for overactive bladder. Int Urogynecol J 2022; 33: 703\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=33594517&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs00192-021-04691-4","DOI":"10.1007\/s00192-021-04691-4"},{"key":"ref=9","unstructured":"Felleskatalogen. Preparatomtale for Botox. https:\/\/preparatomtaler.blob.core.windows.net\/spc\/08-6051.pdf Lest 22.7.2025."}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["Cystoskopisk injeksjon av botulinumtoksin for overaktiv bl\u00e6re med lekkasje"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:30:22Z","timestamp":1781710222000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2025\/11\/kort-rapport\/cystoskopisk-injeksjon-av-botulinumtoksin-overaktiv-blaere-med-lekkasje"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":9,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,11,25]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.25.0247","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]}}}